Stock BIOPOR BIOPORTO A/S
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioPorto A/S

Equities

BIOPOR

DK0011048619

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:57 2024-06-10 am EDT 		5-day change 1st Jan Change
1.63 DKK -1.57% Intraday chart for BioPorto A/S -3.89% -22.01%
May. 30 BioPorto A/S Appoints Niels Høy Nielsen as Member of the Executive Management Team, Effective August 1, 2024 CI
May. 30 BioPorto A/S Appoints Niels Høy Nielsen as Chief Financial Officer, Effective August 1, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 512.5 1,077 661.3 774.8 793.5 628.7
Enterprise Value (EV) 1 496 1,077 661.3 774.8 793.5 628.7
P/E ratio -7.15 x -13.5 x -11.8 x -9.65 x -13.1 x -16.6 x
Yield - - - - - -
Capitalization / Revenue 19.3 x 46.4 x 27.3 x 26.7 x 25.6 x 15.7 x
EV / Revenue 19.3 x 46.4 x 27.3 x 26.7 x 25.6 x 15.7 x
EV / EBITDA -7,500,752 x - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 174,931 266,569 267,741 334,680 379,657 379,657
Reference price 2 2.930 4.040 2.470 2.315 2.090 1.656
Announcement Date 2/26/20 3/17/21 4/6/22 3/30/23 4/4/24 -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 26.62 23.2 24.25 28.97 30.96 40
EBITDA -68.33 - - - - -
EBIT 1 -74.3 -63.59 -65.26 -78.94 -60.16 -41
Operating Margin -279.09% -274.05% -269.05% -272.51% -194.34% -102.5%
Earnings before Tax (EBT) 1 -74.25 -66.83 -63.84 -81.55 -61.21 -41
Net income 1 -69.64 -61.56 -57.11 -75.92 -56.33 -38.13
Net margin -261.6% -265.31% -235.48% -262.08% -181.95% -95.32%
EPS 2 -0.4100 -0.3000 -0.2100 -0.2400 -0.1600 -0.1000
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/26/20 3/17/21 4/6/22 3/30/23 4/4/24 -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 6.807 6.502 8.506 5.3 8.69 8.041 7.748 8.6 6.56 9.461 8.4 10.3 13.3
EBITDA - - - - - - - - - - - - -
EBIT -18.09 -18.22 -20.14 - -20.62 -16.95 -20.86 - -11.98 - - - -
Operating Margin -265.7% -280.19% -236.74% - -237.28% -210.79% -269.17% - -182.65% - - - -
Earnings before Tax (EBT) -17.74 -18.28 -19.38 - -25.1 -17.2 -20.97 - -12.42 - - - -
Net income -16.74 -17.03 -17.09 - -24.92 -16.06 -19.65 - -11.02 - - - -
Net margin -245.95% -261.92% -200.93% - -286.82% -199.73% -253.6% - -168% - - - -
EPS 2 -0.0600 -0.0600 -0.0500 - -0.0800 -0.0500 -0.0600 - -0.0300 -0.0400 -0.0300 -0.0200 -0.0200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 4/6/22 5/11/22 8/17/22 11/9/22 3/30/23 5/10/23 8/1/23 10/31/23 4/4/24 5/8/24 - - -
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position 16.6 - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 2.06 1.32 - - - -
Capex / Sales 7.75% 5.67% - - - -
Announcement Date 2/26/20 3/17/21 4/6/22 3/30/23 4/4/24 -
1DKK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.656 DKK
Average target price
5 DKK
Spread / Average Target
+201.93%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
BIOPORTO A/S Stock BioPorto A/S
-22.01% 91.08M
BIOMÉRIEUX Stock bioMérieux
-8.75% 11.98B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-5.68% 8B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+7.57% 5.85B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+27.60% 5.54B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-15.84% 3.84B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+10.70% 2.66B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-61.18% 2.62B
VITROLIFE AB Stock Vitrolife AB
-8.12% 2.33B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+12.43% 2B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. BIOPOR Stock
  4. Financials BioPorto A/S